BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 7775082)

  • 1. [Incretin research in the development of new strategies of diabetes therapy].
    Göke B; Göke R; Fehmann HC; Arnold R
    Internist (Berl); 1995 Apr; 36(4):343-9. PubMed ID: 7775082
    [No Abstract]   [Full Text] [Related]  

  • 2. Cell and molecular biology of the incretin hormones glucagon-like peptide-I and glucose-dependent insulin releasing polypeptide.
    Fehmann HC; Göke R; Göke B
    Endocr Rev; 1995 Jun; 16(3):390-410. PubMed ID: 7671853
    [No Abstract]   [Full Text] [Related]  

  • 3. Glucagon and its family revisited.
    Lefèbvre PJ
    Diabetes Care; 1995 May; 18(5):715-30. PubMed ID: 8586014
    [No Abstract]   [Full Text] [Related]  

  • 4. [Glucagon-like peptide-1 (GLP-1) receptor].
    Taminato T
    Nihon Rinsho; 2002 Jul; 60 Suppl 7():535-41. PubMed ID: 12238094
    [No Abstract]   [Full Text] [Related]  

  • 5. [GIP and GLP-1: multiplicity of regulator mechanisms for insulin secretion].
    Thorens B
    Journ Annu Diabetol Hotel Dieu; 2004; ():111-25. PubMed ID: 15259310
    [No Abstract]   [Full Text] [Related]  

  • 6. Overview of incretin hormones.
    Efendic S; Portwood N
    Horm Metab Res; 2004; 36(11-12):742-6. PubMed ID: 15655702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New developments in the biology of the glucagon-like peptides GLP-1 and GLP-2.
    Drucker DJ; Lovshin J; Baggio L; Nian M; Adatia F; Boushey RP; Liu Y; Saleh J; Yusta B; Scrocchi L
    Ann N Y Acad Sci; 2000; 921():226-32. PubMed ID: 11193827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GIP and GLP-1 as incretin hormones: lessons from single and double incretin receptor knockout mice.
    Hansotia T; Drucker DJ
    Regul Pept; 2005 Jun; 128(2):125-34. PubMed ID: 15780432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The glucagon-like peptides: a double-edged therapeutic sword?
    Perry T; Greig NH
    Trends Pharmacol Sci; 2003 Jul; 24(7):377-83. PubMed ID: 12871671
    [No Abstract]   [Full Text] [Related]  

  • 10. Glucagon-like peptide-1 (GLP-1): a gut hormone of potential interest in the treatment of diabetes.
    Ahrén B
    Bioessays; 1998 Aug; 20(8):642-51. PubMed ID: 9780839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucagon-like peptide-I and the control of insulin secretion in the normal state and in NIDDM.
    Thorens B; Waeber G
    Diabetes; 1993 Sep; 42(9):1219-25. PubMed ID: 8349031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Gluco-incretin hormones in insulin secretion and diabetes].
    Thorens B
    Med Sci (Paris); 2003; 19(8-9):860-3. PubMed ID: 14593618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is glucagon-like peptide 1 an incretin hormone?
    Nauck MA
    Diabetologia; 1999 Mar; 42(3):373-9. PubMed ID: 10096792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucagon-like peptide-1(7-37)/(7-36)amide is a new incretin.
    Fehmann HC; Göke R; Göke B
    Mol Cell Endocrinol; 1992 May; 85(1-2):C39-44. PubMed ID: 1382025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucagon-like peptide-1 is a physiological incretin in rat.
    Wang Z; Wang RM; Owji AA; Smith DM; Ghatei MA; Bloom SR
    J Clin Invest; 1995 Jan; 95(1):417-21. PubMed ID: 7814643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of endogenous glucagon-like peptide-1 in islet regeneration after partial pancreatectomy.
    De León DD; Deng S; Madani R; Ahima RS; Drucker DJ; Stoffers DA
    Diabetes; 2003 Feb; 52(2):365-71. PubMed ID: 12540609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Black widow spider alpha-latrotoxin: a presynaptic neurotoxin that shares structural homology with the glucagon-like peptide-1 family of insulin secretagogic hormones.
    Holz GG; Habener JF
    Comp Biochem Physiol B Biochem Mol Biol; 1998 Oct; 121(2):177-84. PubMed ID: 9972293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucagon-like peptide-1 structure, function and potential use for NIDDM.
    Gefel D; Barg Y; Zimlichman R
    Isr J Med Sci; 1997 Oct; 33(10):690-5. PubMed ID: 9397146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic stability, receptor binding, cAMP generation, insulin secretion and antihyperglycaemic activity of novel N-terminal Glu9-substituted analogues of glucagon-like peptide-1.
    Green BD; Gault VA; Irwin N; Mooney MH; Bailey CJ; Harriott P; Greer B; Flatt PR; O'Harte FP
    Biol Chem; 2003 Dec; 384(12):1543-51. PubMed ID: 14719796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transfection of pancreatic-derived beta-cells with a minigene encoding for human glucagon-like peptide-1 regulates glucose-dependent insulin synthesis and secretion.
    Hui H; Yu R; Bousquet C; Perfetti R
    Endocrinology; 2002 Sep; 143(9):3529-39. PubMed ID: 12193567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.